Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CPerspective Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Perspective Therapeutics, Inc.

$2.71Close · Oct 8, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q3 ’23201720182019202020212022202320252026-8M-6M-4M-2M02MLatest period Q3 '23. Revenue 2.19M. Gross profit 738K. Net profit -9.57M.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q3 ’232017201820192020202120222023202520260500K1M1.5M2M2.5M
BrachytherapyDrug Operations
See how much of the company’s revenue comes from each customer it reports as 10% or more of revenue. Filings often name these customers only as Customer A, Customer B, and so on.Formula: Customer share = customer revenue ÷ total revenue × 100% Other customers = 100% − Σ(major customer shares)
Q1 ’222017201820192020202120232024202520260%20%40%60%80%100%
      Latest period Q3 '22. El Camino Los Gatos Other Facilities 26.9%. GT Medical Technologies Inc 13.4%. Other customers 59.7%.
      El Camino Los Gatos Other FacilitiesGT Medical Technologies IncOther customers
      See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
      Q3 ’23201720182019202020212022202320252026-400%-300%-200%-100%0%Latest period Q3 '23. Gross margin 33.8%. Operating margin -446.2%. Net profit margin -438.1%.
      Gross marginOperating marginNet profit margin
      See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
      Q2 ’18201720202021202220232024202520260500K1M1.5M2M
          Latest period Q4 '18. Purchase & other commitments 2.3M.
          Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
          Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
          $
          Q2 ’26201720182019202020212022202320242025-40M-30M-20M-10M010M
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            • Capex: purchases of property, plant and equipment
            Latest period Q2 '26. Operating cash flow -20.7M. Capex -14.2M. Free cash flow -34.8M.
            Operating cash flowCapexFree cash flow
            Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
            2026201720182019202020212022202320242025050M100M150M200M250M
                Latest period 2026. Cash 48.5M. Debt 1.6M.
                CashDebtNet cash
                Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
                $/shareUsing split history cached 2026-10-08; assuming no new splits
                Q2 ’26201720182019202020212022202320242025-15.00-10.00-5.000.00
                  • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 55,017,419 source shares.
                  • Earnings period 2016-07-01 to 2017-06-30. Shares as of 2017-06-30: 55,017,419 source shares.
                  • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 55,017,419 source shares.
                  • Earnings period 2017-10-01 to 2017-12-31. Shares as of 2017-12-31: 55,100,229 source shares.
                  • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 55,100,229 source shares.
                  • Earnings period 2017-07-01 to 2018-06-30. Shares as of 2018-06-30: 56,331,147 source shares.
                  • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 67,331,147 source shares.
                  • Earnings period 2018-10-01 to 2018-12-31. Shares as of 2018-12-31: 67,331,147 source shares.
                  • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 67,338,047 source shares.
                  • Earnings period 2018-07-01 to 2019-06-30. Shares as of 2019-06-30: 67,388,047 source shares.
                  • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 67,388,047 source shares.
                  • Earnings period 2019-10-01 to 2019-12-31. Shares as of 2019-12-31: 67,388,047 source shares.
                  • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 67,650,547 source shares.
                  • Earnings period 2019-07-01 to 2020-06-30. Shares as of 2020-06-30: 68,897,779 source shares.
                  • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: 68,897,779 source shares.
                  • Earnings period 2020-10-01 to 2020-12-31. Shares as of 2020-12-31: 87,232,324 source shares.
                  • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-03-31: 141,465,266 source shares.
                  • Earnings period 2020-07-01 to 2021-06-30. Shares as of 2021-06-30: 141,915,266 source shares.
                  • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 141,915,266 source shares.
                  • Earnings period 2021-10-01 to 2021-12-31. Shares as of 2021-12-31: 142,040,266 source shares.
                  • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 142,040,266 source shares.
                  • Earnings period 2021-07-01 to 2022-06-30. Shares as of 2022-06-30: 142,040,266 source shares.
                  • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 142,112,766 source shares.
                  • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 142,112,766 source shares.
                  • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 278,657,841 source shares.
                  • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 280,479,421 source shares.
                  • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 280,571,026 source shares.
                  • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 28,180,985 source shares.
                  • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 586,915,977 source shares.
                  • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 67,425,167 source shares.
                  • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 67,562,781 source shares.
                  • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 70,671,464 source shares.
                  • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 74,050,841 source shares.
                  • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 74,262,990 source shares.
                  • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 74,337,990 source shares.
                  • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 74,337,990 source shares.
                  • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 114,017,755 source shares.
                  • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 114,086,092 source shares.
                  Latest period Q2 2026. EPS (TTM) -1.02.
                  EPS (TTM)
                  How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
                  Using split history cached 2026-10-08; assuming no new splits
                  Q2 ’26201720182019202020212022202320242025-40x-30x-20x-10x0x
                    • Earnings period 2017-01-01 to 2017-03-31. Shares as of 2017-03-31: 55,017,419 source shares. Weekly price on 2017-03-31.
                    • Earnings period 2016-07-01 to 2017-06-30. Shares as of 2017-06-30: 55,017,419 source shares. Weekly price on 2017-06-30.
                    • Earnings period 2017-07-01 to 2017-09-30. Shares as of 2017-09-30: 55,017,419 source shares. Nearby weekly price on 2017-10-06.
                    • Earnings period 2017-10-01 to 2017-12-31. Shares as of 2017-12-31: 55,100,229 source shares. Nearby weekly price on 2017-12-29.
                    • Earnings period 2018-01-01 to 2018-03-31. Shares as of 2018-03-31: 55,100,229 source shares. Nearby weekly price on 2018-03-29.
                    • Earnings period 2017-07-01 to 2018-06-30. Shares as of 2018-06-30: 56,331,147 source shares. Nearby weekly price on 2018-06-29.
                    • Earnings period 2018-07-01 to 2018-09-30. Shares as of 2018-09-30: 67,331,147 source shares. Nearby weekly price on 2018-09-28.
                    • Earnings period 2018-10-01 to 2018-12-31. Shares as of 2018-12-31: 67,331,147 source shares. Nearby weekly price on 2018-12-28.
                    • Earnings period 2019-01-01 to 2019-03-31. Shares as of 2019-03-31: 67,338,047 source shares. Nearby weekly price on 2019-03-29.
                    • Earnings period 2018-07-01 to 2019-06-30. Shares as of 2019-06-30: 67,388,047 source shares. Nearby weekly price on 2019-06-28.
                    • Earnings period 2019-07-01 to 2019-09-30. Shares as of 2019-09-30: 67,388,047 source shares. Nearby weekly price on 2019-09-27.
                    • Earnings period 2019-10-01 to 2019-12-31. Shares as of 2019-12-31: 67,388,047 source shares. Nearby weekly price on 2020-01-03.
                    • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: 67,650,547 source shares. Nearby weekly price on 2020-04-03.
                    • Earnings period 2019-07-01 to 2020-06-30. Shares as of 2020-06-30: 68,897,779 source shares. Nearby weekly price on 2020-07-02.
                    • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: 68,897,779 source shares. Nearby weekly price on 2020-10-02.
                    • Earnings period 2020-10-01 to 2020-12-31. Shares as of 2020-12-31: 87,232,324 source shares. Weekly price on 2020-12-31.
                    • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-03-31: 141,465,266 source shares. Nearby weekly price on 2021-04-01.
                    • Earnings period 2020-07-01 to 2021-06-30. Shares as of 2021-06-30: 141,915,266 source shares. Nearby weekly price on 2021-07-02.
                    • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 141,915,266 source shares. Nearby weekly price on 2021-10-01.
                    • Earnings period 2021-10-01 to 2021-12-31. Shares as of 2021-12-31: 142,040,266 source shares. Weekly price on 2021-12-31.
                    • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 142,040,266 source shares. Nearby weekly price on 2022-04-01.
                    • Earnings period 2021-07-01 to 2022-06-30. Shares as of 2022-06-30: 142,040,266 source shares. Nearby weekly price on 2022-07-01.
                    • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 142,112,766 source shares. Weekly price on 2022-09-30.
                    • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 142,112,766 source shares. Nearby weekly price on 2022-12-30.
                    • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 278,657,841 source shares. Weekly price on 2023-03-31.
                    • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 280,479,421 source shares. Weekly price on 2023-06-30.
                    • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 280,571,026 source shares. Nearby weekly price on 2023-09-29.
                    • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 28,180,985 source shares. Nearby weekly price on 2023-12-29.
                    • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 586,915,977 source shares. Nearby weekly price on 2024-03-28.
                    • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 67,425,167 source shares. Nearby weekly price on 2024-06-28.
                    • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 67,562,781 source shares. Nearby weekly price on 2024-09-27.
                    • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 70,671,464 source shares. Nearby weekly price on 2025-01-03.
                    • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 74,050,841 source shares. Nearby weekly price on 2025-03-28.
                    • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 74,262,990 source shares. Nearby weekly price on 2025-06-27.
                    • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 74,337,990 source shares. Nearby weekly price on 2025-10-03.
                    • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 74,337,990 source shares. Nearby weekly price on 2026-01-02.
                    • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 114,017,755 source shares. Nearby weekly price on 2026-04-02.
                    • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 114,086,092 source shares. Nearby weekly price on 2026-07-02.
                    Latest period Q2 2026. P/E ratio -3.6x.
                    P/E ratio
                    See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
                    Stock split history may be out of date.
                    20262017201820192020202120222023202420250100M200M300M400M500M
                    2024-06-17: Reverse stock split 1-for-10
                        Latest period 2026. Shares outstanding 114.1M. Class detail unavailable 114.1M.
                        Class detail unavailableStock split